annual CFO:
-$43.81M+$6.76M(+13.37%)Summary
- As of today (June 17, 2025), JANX annual cash flow from operations is -$43.81 million, with the most recent change of +$6.76 million (+13.37%) on December 31, 2024.
- During the last 3 years, JANX annual CFO has fallen by -$26.84 million (-158.09%).
- JANX annual CFO is now -1044.57% below its all-time high of -$3.83 million, reached on December 31, 2019.
Performance
JANX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$17.02M-$299.00K(-1.79%)Summary
- As of today (June 17, 2025), JANX quarterly cash flow from operations is -$17.02 million, with the most recent change of -$299.00 thousand (-1.79%) on March 31, 2025.
- Over the past year, JANX quarterly CFO has dropped by -$2.19 million (-14.74%).
- JANX quarterly CFO is now -406.02% below its all-time high of $5.56 million, reached on March 31, 2021.
Performance
JANX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$46.00M-$2.19M(-4.99%)Summary
- As of today (June 17, 2025), JANX TTM cash flow from operations is -$46.00 million, with the most recent change of -$2.19 million (-4.99%) on March 31, 2025.
- Over the past year, JANX TTM CFO has increased by +$5.50 million (+10.68%).
- JANX TTM CFO is now -2322.27% below its all-time high of $2.07 million, reached on March 31, 2021.
Performance
JANX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
JANX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.4% | -14.7% | +10.7% |
| 3 y3 years | -158.1% | -47.8% | -35.0% |
| 5 y5 years | -1044.6% | -1843.4% | -5151.3% |
JANX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -158.1% | +13.4% | -663.1% | at low | -35.6% | +15.3% |
| 5 y | 5-year | -1044.6% | +13.4% | -406.0% | at low | -2322.3% | +15.3% |
| alltime | all time | -1044.6% | +13.4% | -406.0% | at low | -2322.3% | +15.3% |
JANX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$17.02M(+1.8%) | -$46.00M(+5.0%) |
| Dec 2024 | -$43.81M(-13.4%) | -$16.73M(+649.7%) | -$43.81M(+18.4%) |
| Sep 2024 | - | -$2.23M(-77.7%) | -$36.99M(-20.4%) |
| Jun 2024 | - | -$10.02M(-32.5%) | -$46.47M(-9.8%) |
| Mar 2024 | - | -$14.84M(+49.9%) | -$51.50M(+1.8%) |
| Dec 2023 | -$50.58M(+17.8%) | -$9.90M(-15.4%) | -$50.58M(-3.8%) |
| Sep 2023 | - | -$11.71M(-22.2%) | -$52.59M(-3.1%) |
| Jun 2023 | - | -$15.05M(+8.2%) | -$54.29M(+19.8%) |
| Mar 2023 | - | -$13.91M(+16.8%) | -$45.31M(+5.6%) |
| Dec 2022 | -$42.92M | -$11.91M(-11.2%) | -$42.92M(+3.5%) |
| Sep 2022 | - | -$13.41M(+120.9%) | -$41.49M(+22.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$6.07M(-47.3%) | -$33.93M(-0.4%) |
| Mar 2022 | - | -$11.52M(+9.9%) | -$34.06M(+100.6%) |
| Dec 2021 | -$16.98M(+288.6%) | -$10.48M(+79.0%) | -$16.98M(+109.0%) |
| Sep 2021 | - | -$5.85M(-5.6%) | -$8.12M(+142.3%) |
| Jun 2021 | - | -$6.20M(-211.5%) | -$3.35M(-262.0%) |
| Mar 2021 | - | $5.56M(-441.5%) | $2.07M(-147.4%) |
| Dec 2020 | -$4.37M(+14.1%) | -$1.63M(+50.4%) | -$4.37M(+59.5%) |
| Sep 2020 | - | -$1.08M(+38.7%) | -$2.74M(+65.4%) |
| Jun 2020 | - | -$781.00K(-10.8%) | -$1.66M(+89.2%) |
| Mar 2020 | - | -$876.00K | -$876.00K |
| Dec 2019 | -$3.83M | - | - |
FAQ
- What is Janux Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Janux Therapeutics?
- What is Janux Therapeutics annual CFO year-on-year change?
- What is Janux Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Janux Therapeutics?
- What is Janux Therapeutics quarterly CFO year-on-year change?
- What is Janux Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Janux Therapeutics?
- What is Janux Therapeutics TTM CFO year-on-year change?
What is Janux Therapeutics annual cash flow from operations?
The current annual CFO of JANX is -$43.81M
What is the all time high annual CFO for Janux Therapeutics?
Janux Therapeutics all-time high annual cash flow from operations is -$3.83M
What is Janux Therapeutics annual CFO year-on-year change?
Over the past year, JANX annual cash flow from operations has changed by +$6.76M (+13.37%)
What is Janux Therapeutics quarterly cash flow from operations?
The current quarterly CFO of JANX is -$17.02M
What is the all time high quarterly CFO for Janux Therapeutics?
Janux Therapeutics all-time high quarterly cash flow from operations is $5.56M
What is Janux Therapeutics quarterly CFO year-on-year change?
Over the past year, JANX quarterly cash flow from operations has changed by -$2.19M (-14.74%)
What is Janux Therapeutics TTM cash flow from operations?
The current TTM CFO of JANX is -$46.00M
What is the all time high TTM CFO for Janux Therapeutics?
Janux Therapeutics all-time high TTM cash flow from operations is $2.07M
What is Janux Therapeutics TTM CFO year-on-year change?
Over the past year, JANX TTM cash flow from operations has changed by +$5.50M (+10.68%)